Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 2-Oxford to study anti-inflammatory drug Humira as potential COVID-19 treatment

Wed, 30th Sep 2020 10:56

(Adds details)

By Josephine Mason and Kate Kelland

LONDON, Sept 30 (Reuters) - Oxford University said on
Wednesday it would study whether the world's best-selling
prescription medicine, adalimumab, was an effective treatment
for COVID-19 patients - the latest effort to repurpose existing
drugs as potential coronavirus therapies.

Adalimumab, which is sold under the brand name Humira by
AbbVie, is a type of anti-inflammatory known as an
anti-tumour necrosis factor (anti-TNF) drug. Recent studies have
shown that COVID-19 patients already taking anti-TNF drugs for
inflammatory bowel disease and inflammatory arthritis are less
likely to be admitted to hospital, Oxford said in a statement.

Oxford's trial, called AVID-CC, will be aimed at treating
people in the community, especially in care homes, the
university said. It will enrol up to 750 patients from community
care settings throughout Britain.

Humira is used to treat a range of conditions including
rheumatoid arthritis, Crohn’s disease, ulcerative colitis and

The availability of biosimilar versions of the medicine
would make it affordable and accessible if the trial is
successful, Oxford said. Novartis makes one of the
alternatives, Hyrimoz.

Research has identified some treatments for hospitalised
COVID-19 patients, including Gilead's remdesivir as
well as the generic steroid drug dexamethasone.

Researchers have also studied other anti-inflammatory drugs
for treating COVID-19. Severe infections are
believed to be triggered by an over-reaction of the immune
system, known as a cytokine storm, and drugs that suppress
certain elements of the immune system can play a role in
arresting a rapid escalation of symptoms.

But there are as yet no effective therapies for people who
are not admitted to hospital.

Care homes were particularly hard hit by the first wave of
COVID-19 in the UK and other countries. If Humira were
successful against COVID-19, this could help some older people
who are some of most vulnerable, it said, at a time when
governments are struggling to contain the pandemic.

The Oxford study is funded by the COVID-19 Therapeutics
Accelerator initiative set up by global health charity Wellcome,
as well as the Bill and Melinda Gates Foundation and Mastercard.
(Reporting by Josephine Mason and Kate Kelland in London and
John Miller in Zurich
Editing by Mark Heinrich)

More News

UPDATE 1-Santander says all UK services working again after technical difficulties

(Adds latest statement)LONDON, May 15 (Reuters) - Santander told UK customers that all of its banking services were back up and running late on Saturday after technical problems stopped cash withdrawals and online account access for much of the da...

15 May 21 21:29

Soccer-Spotify founder Ek says his bid for Arsenal was rejected

LONDON, May 15 (Reuters) - Spotify CEO and founder Daniel Ek said on Saturday an offer to buy Premier League Arsenal had been rejected by owner Stan Kroenke's family.Ek took to Twitter to issue a statement correcting "inaccurate reports" that he had ...

15 May 21 20:44

Britain reports 2,027 new COVID-19 cases, seven deaths

LONDON, May 15 (Reuters) - Britain reported 2,027 new COVID-19 infections on Saturday, as well as a further seven deaths within 28 days of a positive test.The official data also showed that 36.32 million people had received their first dose of a C...

15 May 21 18:03

Santander says technical difficulties affecting UK customers

LONDON, May 15 (Reuters) - Santander told UK customers on Saturday a technical problem was affecting its services, stopping people from withdrawing funds from some of its cash machines and from logging onto their accounts online.The bank has 14 mi...

15 May 21 14:45

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.